Tizanidine Tablet
Product Images NDC 71205-311

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71205-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure of Tizanidine hydrochloride shown as a molecular diagram with chlorine, sulfur, nitrogen atoms, and ring structures.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A line graph showing plasma tizanidine concentration (ng/mL) over time (hours) after dosing. It compares four different conditions involving 4 mg tizanidine tablets and capsules taken with and without food, illustrating changes in concentration from 0 to 26 hours post-dose.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

A line graph showing improvement in Ashworth Score over 6 hours post-dose comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis measures improvement in score, with 16 mg tizanidine showing the highest improvement, followed by 8 mg and placebo with minimal change.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A chart displaying improvement in Ashworth Score over time comparing tizanidine (mean dose 28.8 mg) and placebo. The x-axis shows three time points: end of titration (Study Week 3), end of maintenance (Study Week 7), and endpoint (last observation carried forward). The y-axis represents improvement, with negative values indicating greater improvement. Tizanidine shows greater reduction in Ashworth Score consistently compared to placebo, with error bars indicating variability.*

FDA Label Image

71205-311-30 (Tizanidine 5)

Tizanidine 2 mg oral tablets packaging label from Proficient Rx LP. The label states each tablet contains 2.288 mg tizanidine HCl equivalent to 2 mg tizanidine base. The package contains #30 uncoated, white to off-white, round, flat beveled tablets with product code "502" debossed on one side. Manufacturer is ALKALOIDA Chemical Company in Hungary. Storage instructions and a warning about non-interchangeability with Tizanidine Capsules are also noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.